Alta Sciences

DECEMBER 14, 2023

A Closer Look At Our On-Site Compounding Pharmacies shajjar Thu, 12/14/2023 - 21:30 HTML Altasciences' dedicated pharmacists bring a wealth of expertise in controlled substances and complex compounding, ensuring maximum precision and safety standards. Electronic security access to the pharmacy and video monitoring. -

Compounding Pharmacies 40

Compounding Pharmacies Pharmacy Clinical Pharmacology Clinical Supply 40

Drugs.com

OCTOBER 15, 2024

15, 2024 -- Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. TUESDAY, Oct. Food and Drug Administration revisits its Oct. 2 decision to remove the medicine from a national drug shortage.

Compounding Pharmacies 89

Compounding Pharmacies Pharmacy FDA Drugs 89

Drugs.com

MARCH 6, 2024

WEDNESDAY, March 6, 2024 -- Barry Cadden, co-founder of a specialty compounding pharmacy behind a deadly meningitis outbreak in 2012, has been handed a prison sentence of 10 to 15 years in Michigan for involuntary manslaughter.On Tuesday, Cadden.

Compounding Pharmacies 119

Compounding Pharmacies Pharmacy 119

Agency IQ

MARCH 25, 2024

FDA addressed the expanding practice of drug compounding in 1992 by issuing a compliance policy guide that clarified that pharmacies which compounded products at certain scales, for certain purposes, or without FDA approval were clearly operating “outside the bounds of traditional pharmacy practice.”

FDA 40

FDA Pharmacy Production Drugs 40

Alta Sciences

MAY 15, 2023

and Canadian CPUs with compounding pharmacies, that are integrated with our bioanalytical labs and manufacturing and analytical campus. Altasciences has U.S. In fact, one of our bioanalytical laboratories is located within a few minutes' drive of our Montréal CPU, contributing to speedy data acquisition.

Drug Development 52

Drug Development Clinical Trials Compounding Pharmacies Laboratories 52

The Pharma Data

MAY 7, 2021

Goldman Sachs jumps aboard Bain-backed 503(b) compounding pharmacy with a $275M debt loan to supply hospitals ( Endpoints ). . Another failed trial for Orphazyme’s ‘pipeline-in-a-product’ leaves shadow on drug’s future ( Endpoints ). Medtech. Generic Drug Cos.

Vaccine 52

Vaccine Compounding Pharmacies Regulations Drugs 52

Agency IQ

FEBRUARY 15, 2024

CDRH FY2024 Guidance Agenda Clinical application Recommendations for Investigational and Licensed COVID-19 Convalescent Plasma CBER Final By 12/31/24 CBER CY 2024 Guidance Agenda Blood Considerations for the Development of Blood Collection, Processing, and Storage Systems for the Manufacture of Blood Components Using the Buffy Coat Method CBER Draft (..)

FDA 40

FDA Science Biosimilars Clinical Trials 40